Biology Before Psychology
OmTerra provides compassionate, empathetic, and caring support for individuals seeking long-term healing from trauma, Post-Traumatic Stress Disorder (PTSD), anxiety, and depression through a unique form of psychedelic somatic therapy. Our holistic approach prioritizes addressing the biological aspects of trauma before delving into psychological aspects. This is achieved through Psychedelic Somatic Interactional Psychotherapy (PSIP), combined with "parts work" derived from the Internal Family Systems therapy model. Unlike other somatic approaches, our model harnesses the inherent healing abilities of the autonomic nervous system while incorporating legally accessible psychedelic medicines, as provided by the patient, to facilitate trauma release and processing.
As part of our holistic approach at OmTerra, we acknowledge the interconnectedness of the body, mind, and spirit. We recognize the body as the foundational core of one's healing journey, as it is where trauma, anxiety, and depression often reside. When addressing trauma or PTSD, it is essential to begin by working with the body before venturing into deeper explorations of transpersonal or transcendent aspects.
In collaboration with the mind, we assist individuals in untangling habitual patterns of thinking that have developed as coping mechanisms for managing trauma. Finally, when an individual feels prepared, we can facilitate transformative experiences of the spirit, allowing for further personal growth and exploration.
At OmTerra, we believe in a comprehensive approach that encompasses the integration of body, mind, and spirit to support individuals on their healing path. Through our unique blend of psychedelic somatic therapy, parts work, and a deep respect for each person's unique journey, we strive to create a safe and nurturing environment for profound healing and transformation.
Steve, OmTerra Founder and Psychedelic Somatic Interactional Therapist, is also the Co-Founder of the Psychedelic Somatic Institute (PSI), a psychedelic somatic therapist training organization and OmTerra, a PSIP/IFS focused therapy organization. He was a participant in the 2015, Phase 1 FDA Pharmacokinetic Study of Psilocybin at UW-Madison that also studied the effects of high-dose psilocybin for adverse reactions. Steven had a first-hand experience of the benefits and shortcomings of the current non-directive model used in psychedelic therapy worldwide. This led him to creating OmTerra and PSI to expand the potential of psychedelic medicines utilizing a somatic focus. Steve has been a pioneer in bringing more awareness to the world of the powerful transformative effects of psychedelics and the more harrowing and less discussed challenges that come with psychedelic therapy. Steve is also someone who has his own history of early childhood trauma and working through it utilizing psychedelic medicines.
A body focused approach for dealing with anxiety, depression and PTSD. OmTerra utilizes cannabis and ketamine when working in this model.
We are not currently offering psilocybin therapy. Steve is enrolled with Synaptic and will be providing psilocybin sessions in Q3 2023.